885 Cambie Street
Suite 2500
Vancouver, BC V6B 0R6
Canada
604 416 7777
https://www.preveceutical.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Stephen Van Deventer | Chairman, CEO & CFO | 84,06k | N/A | 1969 |
Dr. Makarand Jawadekar Ph.D. | Chief Science Officer, President & Director | 51,3k | N/A | 1951 |
Mr. Shawn Sadler | Head of Artificial Intelligence | N/A | N/A | N/A |
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.
PreveCeutical Medical Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.